1.96
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.12 | -5.77% | 1.96 | 1.94 | 2.09 | 2.09 | 2.08 | 17:22:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.94 | 2.10 | 0.16 | 7.62% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 190 | 43,666 | $ 2.00 | $ 87,342 | 209,139 | 0.50 - 5.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:22:00 | 50 | $ 1.96 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 22.35M | 11.40M | 7.74M | $ 1.11M | $ - | -0.23 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 32.10% |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.18 | 2.25 | 1.90 | 2.02 | 73,364 | -0.22 | -10.09% |
| 1 Month | 1.75 | 2.60 | 1.60 | 2.05 | 198,914 | 0.21 | 12.0% |
| 3 Months | 2.78 | 4.00 | 1.27 | 2.39 | 273,538 | -0.82 | -29.5% |
| 6 Months | 0.88 | 5.10 | 0.515 | 3.12 | 595,843 | 1.08 | 122.73% |
| 1 Year | 1.46 | 5.10 | 0.50 | 3.05 | 305,067 | 0.50 | 34.25% |
| 3 Years | 3.70 | 5.10 | 0.50 | 3.01 | 121,340 | -1.74 | -47.03% |
| 5 Years | 3.19 | 7.24 | 0.50 | 3.84 | 182,658 | -1.23 | -38.56% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
